Erik P. Castle

Tulane University — United States

Medicine · Health Sciences

65h-index42.9kcitations369works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(92), Urological Disorders and Treatments(74), Renal cell carcinoma treatment(72), Urinary and Genital Oncology Studies(47), Prostate Cancer Diagnosis and Treatment(45)

Publications337 total

Comparison of Complication and Readmission Rates Between Robot-Assisted and Open Radical Cystectomy: Results From the Randomized RAZOR Clinical Trial
The Journal of Urology·2025· 3 cited
Robot-Assisted Retroperitoneal Lymph Node Dissection
2025
<scp>SETD2</scp> loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a <scp>TGF</scp>‐β‐independent manner
Molecular Oncology·2023· 6 citedOpen Access
Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome
Clinical Epigenetics·2023· 9 citedOpen Access
Supplemental Table from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Data from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Supplemental Table from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
Data from Molecular Inhibitor of QSOX1 Suppresses Tumor Growth &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from Molecular Inhibitor of QSOX1 Suppresses Tumor Growth &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Data from Molecular Inhibitor of QSOX1 Suppresses Tumor Growth &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Data from Molecular Inhibitor of QSOX1 Suppresses Tumor Growth &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2023Open Access
V01-03 USE OF INTESTINAL BOWEL SEGMENTS FOR ADVANCED ROBOTIC RECONSTRUCTIVE SURGERY
The Journal of Urology·2022
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence
JAMA Network Open·2022· 22 citedOpen Access
Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
Kidney Cancer·2022· 4 citedOpen Access
V03-06 ZINNER SYNDROME, ROBOTIC MANAGEMENT IN PEDIATRIC PATIENTS WITH SEMINAL VESICLE CYSTS
The Journal of Urology·2021
V10-11 INTRAOPERATIVE COMPLICATIONS OF ROBOTIC-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL URINARY DIVERSION
The Journal of Urology·2021
Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study
World Journal of Urology·2021· 21 cited
Learning Curve for Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection
Journal of Endourology·2021· 12 cited
Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer
Clinical Epigenetics·2021· 11 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Raju Thomas(17), Paul E. Andrews(16), Fatih Atuğ(10), Raj S. Pruthi(9), Rodney Davis(9), Adam S. Kibel(8), Mani Menon(6), Alexandre Mottrie(6), Peter Wiklund(6), Scott V. Burgess(6), Robert G. Ferrigni(6), Mitchell R. Humphreys(6), Michael Woods(5), Daniel A. Barocas(5), Prokar Dasgupta(5), Khurshid A. Guru(5), James O. Peabody(5), Alon Z. Weizer(4), Ahmad Shabsigh(4), Lee Richstone(4)